Other Events ·
Shareholders approve Neogen's Amended and Restated Omnibus Incentive Plan authorizing up to 31,350,000 shares
NEOGNeogen Corp
Neogen Corporation shareholders approved the Amended and Restated Omnibus Incentive Plan at the annual meeting on October 1, 2026. The plan amends the existing 2023 Omnibus Incentive Plan and authorizes the issuance of up to 31,350,000 shares for equity-based awards, including stock options, restricted stock units, and performance stock units, available to employees and non-employee directors. Neogen Corporation develops and markets biological test kits and sanitizers for food safety.